Alnylam Pharmaceuticals
ALNY
ALNY
585 hedge funds and large institutions have $30B invested in Alnylam Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 94 funds opening new positions, 235 increasing their positions, 180 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
2.58% more ownership
Funds ownership: 96.4% → 98.99% (+2.6%)
12% less capital invested
Capital invested by funds: $34B → $30B (-$4B)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
585
Holding in Top 10
4
Calls
$195M
Puts
$166M
Top Buyers
| 1 | +$406M | |
| 2 | +$293M | |
| 3 | +$78.4M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$74.2M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$72.4M |
Top Sellers
| 1 | -$601M | |
| 2 | -$279M | |
| 3 | -$199M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$178M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$55.1M |